180 related articles for article (PubMed ID: 33046513)
1. Intratumoral Injection of
Janku F; Zhang HH; Pezeshki A; Goel S; Murthy R; Wang-Gillam A; Shepard DR; Helgason T; Masters T; Hong DS; Piha-Paul SA; Karp DD; Klang M; Huang SY; Sakamuri D; Raina A; Torrisi J; Solomon SB; Weissfeld A; Trevino E; DeCrescenzo G; Collins A; Miller M; Salstrom JL; Korn RL; Zhang L; Saha S; Leontovich AA; Tung D; Kreider B; Varterasian M; Khazaie K; Gounder MM
Clin Cancer Res; 2021 Jan; 27(1):96-106. PubMed ID: 33046513
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses.
Roberts NJ; Zhang L; Janku F; Collins A; Bai RY; Staedtke V; Rusk AW; Tung D; Miller M; Roix J; Khanna KV; Murthy R; Benjamin RS; Helgason T; Szvalb AD; Bird JE; Roy-Chowdhuri S; Zhang HH; Qiao Y; Karim B; McDaniel J; Elpiner A; Sahora A; Lachowicz J; Phillips B; Turner A; Klein MK; Post G; Diaz LA; Riggins GJ; Papadopoulos N; Kinzler KW; Vogelstein B; Bettegowda C; Huso DL; Varterasian M; Saha S; Zhou S
Sci Transl Med; 2014 Aug; 6(249):249ra111. PubMed ID: 25122639
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Clostridium novyi-NT spores in dogs with naturally occurring tumors.
Krick EL; Sorenmo KU; Rankin SC; Cheong I; Kobrin B; Thornton K; Kinzler KW; Vogelstein B; Zhou S; Diaz LA
Am J Vet Res; 2012 Jan; 73(1):112-8. PubMed ID: 22204296
[TBL] [Abstract][Full Text] [Related]
4. Immune response to C. novyi-NT immunotherapy.
DeClue AE; Axiak-Bechtel SM; Zhang Y; Saha S; Zhang L; Tung D; Bryan JN
Vet Res; 2018 Apr; 49(1):38. PubMed ID: 29690928
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Potential of
Sharafabad BE; Abdoli A; Abdolmohammadi Khiav L; Meskini M; Jamur P; Dilmaghani A
Curr Cancer Drug Targets; 2023; 23(9):682-696. PubMed ID: 37069721
[TBL] [Abstract][Full Text] [Related]
6. Branched Gold Nanoparticle Coating of Clostridium novyi-NT Spores for CT-Guided Intratumoral Injection.
Park W; Cho S; Huang X; Larson AC; Kim DH
Small; 2017 Feb; 13(5):. PubMed ID: 27862936
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional porous microspheres encapsulating oncolytic bacterial spores and their potential for cancer immunotherapy.
Bae GH; Ryu YH; Han J; Kim SH; Park CG; Park JH; Kim DH; Chon HJ; Kim C; Choi SW; Park W
Biomater Sci; 2023 Jun; 11(13):4652-4663. PubMed ID: 37218418
[No Abstract] [Full Text] [Related]
8. Learning from
Wang L; Wang Q; Tian X; Shi X
J Cancer Res Ther; 2018; 14(Supplement):S1-S6. PubMed ID: 29578142
[TBL] [Abstract][Full Text] [Related]
9. Iron-Oxide Nanocluster Labeling of Clostridium novyi-NT Spores for MR Imaging-Monitored Locoregional Delivery to Liver Tumors in Rat and Rabbit Models.
Ji J; Park WR; Cho S; Yang Y; Li W; Harris K; Huang X; Gu S; Kim DH; Zhang Z; Larson AC
J Vasc Interv Radiol; 2019 Jul; 30(7):1106-1115.e1. PubMed ID: 30952520
[TBL] [Abstract][Full Text] [Related]
10. Clostridium to treat cancer: dream or reality?
Theys J; Lambin P
Ann Transl Med; 2015 May; 3(Suppl 1):S21. PubMed ID: 26046067
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor Effects of Cisplatin Synergist in Combined Treatment with
Ebadi Sharafabad B; Abdoli A; Panahi M; Abdolmohammadi Khiav L; Jamur P; Abedi Jafari F; Dilmaghani A
Adv Pharm Bull; 2023 Nov; 13(4):817-826. PubMed ID: 38022809
[TBL] [Abstract][Full Text] [Related]
12. An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic.
Dailey KM; Small JM; Pullan JE; Winfree S; Vance KE; Orr M; Mallik S; Bayles KW; Hollingsworth MA; Brooks AE
PLoS One; 2023; 18(11):e0289183. PubMed ID: 37963142
[TBL] [Abstract][Full Text] [Related]
13. Clostridium novyi-NT can cause regression of orthotopically implanted glioblastomas in rats.
Staedtke V; Bai RY; Sun W; Huang J; Kibler KK; Tyler BM; Gallia GL; Kinzler K; Vogelstein B; Zhou S; Riggins GJ
Oncotarget; 2015 Mar; 6(8):5536-46. PubMed ID: 25849940
[TBL] [Abstract][Full Text] [Related]
14. Novel insights into the role of Clostridium novyi-NT related combination bacteriolytic therapy in solid tumors.
Feng X; He P; Zeng C; Li YH; Das SK; Li B; Yang HF; Du Y
Oncol Lett; 2021 Feb; 21(2):110. PubMed ID: 33376543
[TBL] [Abstract][Full Text] [Related]
15. Bacteriolytic therapy can generate a potent immune response against experimental tumors.
Agrawal N; Bettegowda C; Cheong I; Geschwind JF; Drake CG; Hipkiss EL; Tatsumi M; Dang LH; Diaz LA; Pomper M; Abusedera M; Wahl RL; Kinzler KW; Zhou S; Huso DL; Vogelstein B
Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15172-7. PubMed ID: 15471990
[TBL] [Abstract][Full Text] [Related]
16. Targeting vascular and avascular compartments of tumors with C. novyi-NT and anti-microtubule agents.
Dang LH; Bettegowda C; Agrawal N; Cheong I; Huso D; Frost P; Loganzo F; Greenberger L; Barkoczy J; Pettit GR; Smith AB; Gurulingappa H; Khan S; Parmigiani G; Kinzler KW; Zhou S; Vogelstein B
Cancer Biol Ther; 2004 Mar; 3(3):326-37. PubMed ID: 14739784
[TBL] [Abstract][Full Text] [Related]
17. MRI-monitored intra-tumoral injection of iron-oxide labeled Clostridium novyi-NT anaerobes in pancreatic carcinoma mouse model.
Zheng L; Zhang Z; Khazaie K; Saha S; Lewandowski RJ; Zhang G; Larson AC
PLoS One; 2014; 9(12):e116204. PubMed ID: 25549324
[TBL] [Abstract][Full Text] [Related]
18. The oncolytic activity of
Abedi Jafari F; Abdoli A; Pilehchian R; Soleimani N; Hosseini SM
Bioimpacts; 2022; 12(5):405-414. PubMed ID: 36381634
[No Abstract] [Full Text] [Related]
19. A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients.
Li JL; Liu HL; Zhang XR; Xu JP; Hu WK; Liang M; Chen SY; Hu F; Chu DT
Gene Ther; 2009 Mar; 16(3):376-82. PubMed ID: 19092859
[TBL] [Abstract][Full Text] [Related]
20. Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a multicentre, phase 1 study.
Querfeld C; Thompson JA; Taylor MH; DeSimone JA; Zain JM; Shustov AR; Johns C; McCann S; Lin GHY; Petrova PS; Uger RA; Molloy N; Shou Y; Akilov OE
Lancet Haematol; 2021 Nov; 8(11):e808-e817. PubMed ID: 34627593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
